首页 正文

Discovery of a potent STAT3 inhibitor WR-S-647 for the treatment of ADPKD

{{output}}
Autosomal dominant polycystic kidney disease (ADPKD) affects approximately 12.5 million individuals globally and is one of the most common causes of end-stage renal disease. It is typically associated with a gradual increase in the volume of numerous cysts in ... ...